HeXun Biosciences Co., Ltd. (TPEX:6986)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.40
-0.90 (-1.18%)
Apr 24, 2025, 1:43 PM CST
12.37%
Market Cap 3.51B
Revenue (ttm) 286.42M
Net Income (ttm) 147.22M
Shares Out 46.00M
EPS (ttm) 3.20
PE Ratio 23.84
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 70,038
Average Volume 173,539
Open 76.90
Previous Close 76.30
Day's Range 75.00 - 77.90
52-Week Range 57.00 - 91.30
Beta n/a
RSI 47.93
Earnings Date May 9, 2025

About HeXun Biosciences

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan. It provides outsourced production services; commissioned development and manufacturing services for various cells and cell derivatives; commissioned inspection; advisory; laboratory information management system; and sterile filling services. The company was founded in 2019 and is based in Taoyuan City, Taiwan. [Read more]

Industry Commercial Physical and Biological Research
Founded 2019
Employees 45
Stock Exchange Taipei Exchange
Ticker Symbol 6986
Full Company Profile

Financial Performance

In 2024, HeXun Biosciences's revenue was 286.42 million, an increase of 119.36% compared to the previous year's 130.57 million. Earnings were 147.22 million, an increase of 339.62%.

Financial Statements

News

There is no news available yet.